Medication info

Huirions Injection 250 IU/mL (Heparin Sodium)

Prescription medicationInjections
Ingredient · strength
Heparin Sodium›Strength being verified
Manufacturer / importer
Huons Co., Ltd.
Appearance
The injection is in a plastic container filled with a colorless to light yellow transparent liquid.
Packaging
Ampoule - 20 milliliters/ampoule [X 50], Ampoule - 10 milliliters/ampoule [X 50]
Approval status
Active

MFDS item code 202004280 · Approved 2020.06.08 · Insurance code 670608621

Summary

Main use
Prevention of blood coagulation during use of an extracorporeal circulation device for hemodialysis
Who uses it
Adults
Adult dosage
This drug is generally administered according to the following dosing regimen; however, the dose should be determined according to the case (e.g., symptoms), site of application, and purpose. Usually, adjust the dose according to age and symptoms so that, after administration of this drug, the whole-blood clotting time (Lee-White method) or whole-blood activated partial thromboplastin time (WBAPTT) is 2~3 times the normal value. Use during extracorporeal circulation (hemodialysis) For artificial kidney treatment, the appropriate dose for each patient is calculated before dialysis based on the results of an individual heparin sensitivity test. With systemic heparinization, 1,000~5,000 units are usually administered before the start of dialysis, followed after dialysis begins by continuous administration of 500~1,500 units per hour or intermittent additional doses of 500~1,500 units every hour. With regional heparinization, infuse 1,500~2,500 units per hour continuously and neutralize with protamine sulfate during extracorporeal circulation.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Prevention of blood coagulation during use of an extracorporeal circulation device for hemodialysis

  • blood clotting
View approved original text

This medicine is used to prevent blood from clotting while using an extracorporeal circulation device during hemodialysis. It helps facilitate the dialysis process and maintains safe blood flow. By preventing blood coagulation, it reduces the risk of complications and contributes to enhancing the treatment effect for patients. Due to this efficacy, it plays an important role in the health management of hemodialysis patients.

Dosage and Administration

Adult dosage

This drug is generally administered according to the following dosing regimen; however, the dose should be determined according to the case (e.g., symptoms), site of application, and purpose. Usually, adjust the dose according to age and symptoms so that, after administration of this drug, the whole-blood clotting time (Lee-White method) or whole-blood activated partial thromboplastin time (WBAPTT) is 2~3 times the normal value. Use during extracorporeal circulation (hemodialysis) For artificial kidney treatment, the appropriate dose for each patient is calculated before dialysis based on the results of an individual heparin sensitivity test. With systemic heparinization, 1,000~5,000 units are usually administered before the start of dialysis, followed after dialysis begins by continuous administration of 500~1,500 units per hour or intermittent additional doses of 500~1,500 units every hour. With regional heparinization, infuse 1,500~2,500 units per hour continuously and neutralize with protamine sulfate during extracorporeal circulation.

Precautions

This drug is a very powerful medication and must only be used under the strict supervision of a physician. It should be administered with particular caution to patients with diseases that pose a high risk of bleeding, as bleeding can occur in nearly all parts of the body in patients receiving this medication. Deathly bleeding may occur; therefore, it must be used with extreme care. Additionally, serious bleeding such as adrenal hemorrhage, ovarian hemorrhage, and retroperitoneal bleeding may occur during the administration of this drug, requiring careful attention. Patients allergic to this medication or those with impaired blood coagulation functions, patients with existing bleeding conditions or those at high risk for bleeding, should not be administered this drug. Patients with severe liver or kidney dysfunction, those who have recently undergone central nervous system or eye surgery, or those who have received spinal anesthesia should also avoid using this medication. Moreover, patients who have experienced severe thrombocytopenia due to this medication or similar drugs should refrain from administration. This drug can cause various side effects, including thrombocytopenia, bleeding, liver dysfunction, allergic reactions, and skin anomalies; therefore, symptoms must be observed attentively during use. Especially, platelet counts should be verified regularly through blood tests, and if they decrease significantly, administration should be stopped immediately. This drug may interact with other medications, and concomitant use with acetylsalicylic acid, non-steroidal anti-inflammatory drugs, and anticoagulants may increase the risk of bleeding, so it is essential to consult a professional. Women who are pregnant or may become pregnant should exercise special caution when using this drug due to risks of uterine and placental bleeding. This medication does not excrete into breast milk and is not absorbed via the gastrointestinal tract, so it is generally not problematic when breastfeeding. In children or the elderly, the risk of bleeding may be higher, so management should be more cautious during use. In cases of overdose, bleeding may worsen, so if overdose is suspected, treatment with the antidote protamine sulfate should be administered immediately, while also being vigilant for side effects during this process. When administering this drug, patient skin and the instruments used must be thoroughly disinfected to prevent injection site infections, and intramuscular injection should be avoided due to the risk of hematoma. Any unused solution after opening should be discarded immediately.

Side effects

  • Hemorrhage
  • fatal hemorrhage
  • adrenal hemorrhage
  • ovarian hemorrhage
  • retroperitoneal hemorrhage
  • gastrointestinal hemorrhage
  • cerebral hemorrhage
  • thrombocytopenia
  • arterial and venous thrombosis
  • acute reversible thrombocytopathy
Show 41 more
  • elevated γ-GTP
  • elevated LDH
  • elevated AST
  • elevated ALT
  • itching
  • urticaria
  • chills
  • fever
  • rhinitis
  • bronchial asthma
  • tearing
  • conjunctivitis
  • cyanosis
  • tachycardia
  • feeling of pressure
  • vasculonervous edema
  • nausea
  • vomiting
  • hypotension
  • dyspnea
  • bronchospasm
  • shock
  • hair loss
  • vitiligo
  • hemorrhagic necrosis
  • hypoaldosteronism
  • osteoporosis
  • rebound effect
  • dyslipidemia
  • renal function inhibition
  • localized painful hematoma
  • priapism
  • diabetes
  • hyperkalemia
  • hyperalkalemia
  • metabolic acidosis
  • elevated lipase
  • vascular spasm reaction
  • erythema
  • mild pain
  • ulcer

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent exposure to air, and it is important to maintain a storage temperature between 1 degree to 30 degrees Celsius. Proper storage will preserve the effectiveness and safety of the medication.

Appearance and packaging

Appearance

The injection is in a plastic container filled with a colorless to light yellow transparent liquid.

Package unit

Ampoule - 20 milliliters/ampoule [X 50], Ampoule - 10 milliliters/ampoule [X 50]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.